C-flex^® and Superflex^® Monofocal

When considering an intraocular lens, what’s important to you?

Reliable optical outcomes and a low rate of post-operative complications

Designed with Rayner’s Anti-Vaulting Haptic (AVH) Technology^®. Our C-flex and Superflex IOL provides proven rotational and centrational stability, and excellent fixation in the capsular bag¹

• Superb centration
• - Maximum offset of only 1 mm 3 months after surgery²
• Excellent rotational and torsional stability

• - 3.1° mean IOL rotation 3 months after surgery²

Reducing dysphotopsia by design¹²

• Rayner’s Enhanced Square Edge Technology shows no general increase in glare from previous models without a square edge⁷
• The low refractive index (1.46) of Rayacryl^®

360° Optimised Barrier to reduce PCO – Low Nd: YAG capsulotomy rates

• Rayner’s 360° Amon-Apple Enhanced Square Edge creates an optimum barrier to reduce epithelial cell migration including at the haptic-optic junction ^7,5

Study of 3,461 patients receiving Rayner 570C IOLs over a 24 month period, Nd:YAG capsulotomy rates were extremely low and comparable with hydrophobic acrylic lenses with square-edge optics⁷

Vacuole free material for a glistening free IOL

• Single piece IOL created from Rayacryl^® an homogeneous material free of microvacuoles, resulting in a glistening free IOL⁸
• Compressible material for delivery through a micro incision
• Excellent handling characteristics with controlled unfolding within the capsular bag
• Low silicone oil adherence⁹
• Excellent uveal biocompatibility¹³
• Hydrophilic acrylic material with low inflammatory response¹⁰

References:

1. Claoué C. Clinical and Surgical Ophthalmology 2008; 26(6): 198-200
2. Alberdi R et al. J Refract Surg. 2012; 28(10):696-700
3. Nanavaty MA et al. J Cataract Refract Surg. 2009; 35:663–671
4. Yagci R et al. Eur J Ophthalmol. 2014 Jul 24; 24(5):688-92
5. Vyas AV et al. J Cataract Refract Surg 2007; 33:81-87
6. Johansson B et al. J Cataract Refract Surg. 2007; 33:1565–1572
7. Mathew RG and Coombes AGA. Ophthalmic Surg Lasers Imaging. 2010 Nov-Dec; 41(6):651-5
8. Rayner. Data on File. White paper
9. McLoone E et al. Br J Ophthalmol. 2001; 85:543–545
10. Richter-Mueksch S et al. J Cataract Refract Surg. 2007; 33:1414–1418
11. Altmann GE et al. J Cataract Refract Surg. 2005; 31(3): 574-585
12. Cezón Prieto J and Bautista MJ. J Cataract Refract Surg. 2010; 36:1508-1516
13. Tomlins PJ et al. J Cataract Refract Surg. 2014; 40:618–625
14. Pepose JS et al. Graefes Arch Clin Exp Ophthalmol. 2009 Jul;247(7):965-73

*Please note that the constants indicated for all Rayner lenses are estimates and are for guidance purposes only. Surgeons must always expect to personalise their own constants based on initial patient outcomes, with further personalisation as the number of eyes increases.

Not all products or offerings are approved or offered in every market and approved labelling and instructions may vary from one country to another. For country specific product information contact your local distributor or email iol_enquires@rayner.com.

Superflex is not approved by the FDA for use or distribution in the United States of America. For FDA status on C-flex please contact the Regulatory Affairs team

Rayner hold a selection of EC certificates for various products. Please contact the Regulatory Affairs team for the current version.